{"doi":"10.3389/fimmu.2018.02315","title":"Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges","abstract":null,"journal":"Frontiers in Immunology","year":2018,"id":630463,"datarank":0.6329261557764161,"base_score":4.219507705176107,"endowment":4.219507705176107,"self_citation_contribution":0.6329261557764161,"citation_network_contribution":0.0,"self_endowment_contribution":0.6329261557764161,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":67,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1633311,"name":"Sara Siris","orcid":null,"position":1,"is_corresponding":false},{"id":1633312,"name":"Camilla A. Gladstone","orcid":null,"position":2,"is_corresponding":false},{"id":42699,"name":"Paul R. Langford","orcid":"0000-0002-6368-4724","position":3,"is_corresponding":false},{"id":1633310,"name":"Fadil A. Bidmos","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges","abstract":"The ongoing, and very serious, threat from antimicrobial resistance necessitates the development and use of preventative measures, predominantly vaccination. Polysaccharide-based vaccines have provided a degree of success in limiting morbidity from disseminated bacterial infections, including those caused by the major human obligate pathogens, Neisseria meningitidis and Streptococcus pneumoniae. Limitations of these polysaccharide vaccines, such as partial coverage and induced escape leading to persistence of disease, provide a compelling argument for the development of protein vaccines. In this review, we briefly chronicle approaches that have yielded licensed vaccines before highlighting reverse vaccinology 2.0 and its potential application in the discovery of novel bacterial protein vaccine candidates. Technical challenges and research gaps are also discussed.","is_dataset_classified":null,"base_score":4.219507705176107,"endowment":4.219507705176107,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"30349542","pmcid":"PMC6187972","openalex_id":"https://openalex.org/W2896035179","authors":[],"funders":[{"funder_name":"Biotechnology and Biological Sciences Research Council","grant_id":"2003843","title":null},{"funder_name":"Medical Research Council","grant_id":"MC_PC_16046","title":null},{"funder_name":"Biotechnology and Biological Sciences Research Council","grant_id":"BB/R505742/1","title":"Optimisation of recombinant expression of patient-derived antibodies and their use to derive vaccines for infectious diseases"},{"funder_name":"Meningitis Now","grant_id":"","title":null},{"funder_name":"Biotechnology and Biological Sciences Research Council","grant_id":"","title":null},{"funder_name":"Imperial College London","grant_id":"","title":null}],"total_grants":6,"fwci":1.8146,"citation_percentile":0.8424692,"influential_citations":0,"citation_trend":[{"year":2019,"count":1},{"year":2020,"count":7},{"year":2021,"count":5},{"year":2022,"count":17},{"year":2023,"count":8},{"year":2024,"count":13},{"year":2025,"count":10},{"year":2026,"count":6}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02315/pdf","host_type":"journal"},{"url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02315/pdf","host_type":"publisher"},{"url":"https://www.frontiersin.org/article/10.3389/fimmu.2018.02315/full","host_type":"publisher"},{"url":"https://doi.org/10.3389/fimmu.2018.02315","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/30349542","host_type":"repository"},{"url":"https://doaj.org/article/4878e10152d54bcc91cb6b210c1c44a1","host_type":"repository"},{"url":"http://europepmc.org/pmc/articles/PMC6187972","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6187972","host_type":"repository"},{"url":"http://www.imperial.ac.uk/people/f.bidmos","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC6187972","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC6187972?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.3389/fimmu.2018.02315","host_type":""},{"url":"https://dx.doi.org/10.3389/fimmu.2018.02315","host_type":""},{"url":"https://ora.ox.ac.uk/objects/uuid:05f74ad1-9dc1-498b-8d24-f14a06651007","host_type":""},{"url":"https://doi.org/https://doi.org/10.3389/fimmu.2018.02315","host_type":""}],"fields_of_study":["Bacterial Infections and Vaccines","vaccines and immunoinformatics approaches","Pneumonia and Respiratory Infections","0301 basic medicine","03 medical and health sciences","0303 health sciences","Animals","Bacterial Infections","Bacterial Vaccines","Humans","Vaccinology"],"mesh_terms":["Vaccinology","Animals","Bacterial Infections","Bacterial Vaccines","Humans"],"keywords":["Reverse vaccinology","Neisseria meningitidis","Streptococcus pneumoniae","Vaccination","Biology","Immunology","Medicine","Virology","Antigen","Microbiology","Bacteria","Epitope","Antibiotics","Immunotherapy","Bacterial Pathogens","Human Monoclonal Antibodies","Reverse Vaccinology 2.0","Vaccine Candidate Antigens","STREPTOCOCCUS-PNEUMONIAE","MENINGOCOCCAL SEROGROUP-B","618","PLASMABLAST ENRICHMENT","HUMAN B-CELLS","Immunotherapeutic agents","616","SOMATIC HYPERMUTATION","Animals","Humans","POTENT NEUTRALIZING ANTIBODIES","Science & Technology","protein vaccines","HUMAN MONOCLONAL-ANTIBODIES","Bacterial Infections","RC581-607","Vaccinology","Bacterial Vaccines","MYCOBACTERIUM-TUBERCULOSIS","Immunologic diseases. Allergy","RAPID GENERATION","Life Sciences & Biomedicine","CONJUGATE VACCINE"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T21:21:50.172988Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}